Research
Metabolic adaptation
Incretin polyagonists significantly reduced body weight compared to placebo (MD -11.47; 95% CI: -14.00 to -8.95).
Incretin polyagonists can be considered effective for weight management in obese patients.
StrongSupportsmedium confidence
Incretin polyagonists significantly reduced body weight compared to placebo (MD -11.47; 95% CI: -14.00 to -8.95).
Why this rating
Based on a systematic review and meta-analysis of randomized controlled trials.
Source
Incretin-Based Dual and Triple Agonists in Overweight or Obese Individuals: A Systematic Review and Meta-Analysis
Zhi Hong Chan et al. · Cardiology in Review · 2026
Meta-analysis
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →